Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 2/20 | 0.46 |
| ▸ | TNKS2 | Q9H2K2 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | PIM1 | P11309 | 1/20 | 0.40 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | KRAS | P01116 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25817310 | 0.84 | TNKS (0.46) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL24222727 | 0.83 | TNKS (0.45) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL25016499 | 0.83 | TNKS (0.45) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL19162691 | 0.81 | TNKS (0.46) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL16919853 | 0.80 | MAPT (0.54) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL19161954 | 0.79 | TNKS (0.47) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL19161622 | 0.77 | TNKS (0.41) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL14090701 | 0.76 | LIMK1 (0.59) | TNKSTNKS2NPSR1LIMK1CDK5 | |
| SCHEMBL19161277 | 0.76 | TNKS (0.45) | TNKSTNKS2MAPTPIM1PIM2 | |
| SCHEMBL19162623 | 0.75 | ELANE (0.41) | TNKSTNKS2MAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180114940-A1 | Organic Electroluminescent Device Comprising a Redox-Doped Electron Transport Layer and an Auxiliary Electron Transport Layer | SAMSUNG SDI CO. LTD. (KR) | 2018-04-26 | — | — | US | disclosed |
| US-20180114921-A1 | Organic Semiconducting Material Comprising an Electrical n-Dopant and an Electron Transport Matrix and Electronic Device Comprising the Semiconducting Material | NOVALED GMBH (DE) | 2018-04-26 | — | — | US | disclosed |
| US-20170213984-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | LG CHEM, LTD. (KR) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114921-A1 | Organic Semiconducting Material Comprising an Electrical n-Dopant and an Electron Transport Matrix and Electronic Device Comprising the Semiconducting Material | OCIAD2, OCIAD1, DRD1 | TNKS 3816/4885TNKS2 3822/4885MAPT 294/4885 |
| US-20180114940-A1 | Organic Electroluminescent Device Comprising a Redox-Doped Electron Transport Layer and an Auxiliary Electron Transport Layer | SLC25A21, MT-ND4L, OXA1L | TNKS 4036/4885TNKS2 3895/4885MAPT 576/4885 |
| US-20170213984-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | CRY1, NOS1, NOLC1 | TNKS 3525/4885TNKS2 4086/4885MAPT 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.